CDH2 and diabetes mellitus: In this study, we aimed to investigate the expression levels of CDH1, CDH2, MCP-1, and PAI-1 mRNAs in blood EVs of overt DN patients, incipient DN patients, DM patients, and healthy controls and determine their diagnostic potential as novel biomarkers for predicting early-stage DN.